ImaRx initiates SonoLysis phase II stroke trial

AuntMinnie.com staff writers
Apr 4, 2005

Pharmaceutical developer ImaRx Therapeutics said the first patient has been treated in a new phase II clinical trial evaluating the safety and effectiveness of its SonoLysis product for the treatment of acute ischemic stroke.

SonoLysis combines external ultrasound and ImaRx's proprietary nanobubble technology to clear blood clots. The evaluation is a multicenter randomized and blinded trial with 40 patients, according to the Tucson, AZ-based firm.

By AuntMinnie.com staff writers
April 5, 2005

Related Reading

ImaRx raises $7 million, March 10, 2005

ImaRx, Guerbet in MR molecular imaging deal, December 10, 2004

ImaRx completes private placement, names chairman, April 2, 2004

ImaRx inks licensing deal, November 19, 2003

Clinical trials begin for ImaRx, September 18, 2003

Copyright © 2005 AuntMinnie.com

Latest in Ultrasound
Liver Anatomy Social
Clinicians need education regarding HCC surveillance resources
May 14, 2024
A case presented at the ARRS annual meeting shows the results of successful microwave ablation (MWA) treatment for a 39-year-old female with metastatic fibrosarcoma of the right axillary sinus.
ARRS: MWA safe, effective method to treat bone metastases
May 10, 2024
Ultrasound Scanner Ultraviolet 400
Deep-learning algorithm improves liver fibrosis diagnosis
April 23, 2024
Screenshot (1142)
POCUS used widely in lung ultrasound applications
April 17, 2024
Related Stories
2005 03 30 15 45 01 706
Ultrasound
Ultrasound separates fracture from metastasis in the ribs
2005 03 25 12 26 30 706
Ultrasound
Late phase best to differentiate focal liver lesions with CEUS
Cc99 Ff Dot
Ultrasound
Contrast US pinpoints focal liver lesions, results in cost-savings
2005 02 07 11 36 54 706
Ultrasound
Ultrasound expands role in incontinence, bladder tumors
More in Ultrasound
Clinicians need education regarding HCC surveillance resources
By Amerigo Allegretto
Clinicians need education to understand hepatocellular carcinoma (HCC) tracking and surveillance resources.
May 14, 2024
Liver Anatomy Social
ARRS: MWA safe, effective method to treat bone metastases
By Amerigo Allegretto
Ultrasound-guided microwave ablation (MWA) is a safe, effective method for treating bone metastases.
May 10, 2024
A case presented at the ARRS annual meeting shows the results of successful microwave ablation (MWA) treatment for a 39-year-old female with metastatic fibrosarcoma of the right axillary sinus.
Deep-learning algorithm improves liver fibrosis diagnosis
By Amerigo Allegretto
An algorithm combining the Fibrosis-4 Index and an ultrasound deep-learning model could improve diagnostic accuracy for advanced liver fibrosis.
April 23, 2024
Ultrasound Scanner Ultraviolet 400
POCUS used widely in lung ultrasound applications
By Amerigo Allegretto
Some of the top domains for users of point-of-care ultrasound (POCUS) incorporate the technology for lung ultrasound applications.
April 17, 2024
Screenshot (1142)
UltraCon: Expert talks ultrasound's role in imaging dense breasts
By Amerigo Allegretto
Kibo Nam, PhD, from Thomas Jefferson University spoke with AuntMinnie.com about the current state of ultrasound in imaging dense breasts.
April 12, 2024
Img 2490
Negative axillary ultrasound can lead to breast biopsy omission
By Amerigo Allegretto
Many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy.
April 12, 2024
Andreas Giannakou, MD, from Brigham & Women’s Hospital and Harvard Medical School presents research highlighting how many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy.
UltraCon: Work-related MSK disorders tied to sonographer burnout
By Amerigo Allegretto
Work-related musculoskeletal (MSK) disorders are tied to work-related burnout among sonographers, according to research highlighted April 10 at UltraCon.
April 11, 2024
Jennifer Bagley from the University of Oklahoma Health Sciences Center presents results at UltraCon suggesting that work-related musculoskeletal disorders are tied to burnout among sonographers.
CEUS adds to locoregional therapy for liver disease
By Amerigo Allegretto
Contrast-enhanced ultrasound (CEUS) can improve locoregional therapy for treating metastatic disease of the liver.
April 11, 2024
Corinne Wessner from Thomas Jefferson University discusses early study results at UltraCon showing the potential of ultrasound-triggered microbubble destruction in treating liver disease.
UltraCon: Harmonic motion imaging tracks breast tumor response to chemo
By Amerigo Allegretto
Harmonic motion imaging can track mechanical property changes of breast tumors in response to neoadjuvant chemotherapy.
April 10, 2024
Yangpei Liu from Columbia University in Ney York City discussed findings at UltraCon suggesting that harmonic motion imaging could be a viable predictor of early treatment response.
UltraCon: Former Medtronic CEO talks ultrasound's future with AuntMinnie.com
By Amerigo Allegretto
Former Medtronic Chairman and CEO Omar Ishrak, PhD, spoke with AuntMinnie.com at UltraCon on the future of ultrasound and market creation.
April 10, 2024
Img 2502
UltraCon: Machine learning predicts sonographer burnout
By Amerigo Allegretto
Machine-learning approaches can predict burnout among sonographers, though established burnout indices may be enough, according to research presented April 9 at UltraCon.
April 9, 2024
Jennifer Bagley from the University of Oklahoma presents findings at UltraCon on the performance of two machine learning approaches in predicting burnout among sonographers.
UltraCon: Ultrasound empowers patients with prosthetic limbs
By Amerigo Allegretto
Gil Weinberg, PhD, a founding director of Georgia Tech's Center for Music Technology, spoke with AuntMinnie.com on ultrasound's use in prosthetics.
April 9, 2024
Img 2547
Page 1 of 509
Next Page